Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Tirzepatide and Semaglutide in Patients at Cardiovascular Risk With Overweight or Obesity But Without Diabetes

NCT07619508 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07619508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07619508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Tirzepatide and Semaglutide in Patients at Cardiovascular Risk With Overweight or Obesity But Without Diabetes
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
February 10, 2026
Completion date
June 1, 2026
Enrollment
100,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight